ArticleBMC musculoskeletal disorders2026
Comparison of the predictive performance of Chang and Baumgaertner reduction quality criteria for cutout complication in geriatric unstable intertrochanteric femur fractures.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this study was to compare the predictive performance of Baumgaertner Reduction Quality Criteria (BRQC) and Chang Reduction Quality Criteria (CRQC) for lag screw cutout in geriatric unstable intertrochanteric femur fractures treated with proximal femoral nailing (PFN). MATERIALS AND
methodsA retrospective study was conducted on 907 patients aged ≥ 65 years who underwent surgery for AO/OTA 31.A2 fractures between January 2018 and January 2026. Among these, 108 patients treated with the same implant (APFN) and meeting the inclusion criteria were included. To reduce the effect of known implant-position-related risk factors for cutout and thereby better isolate the predictive value of reduction quality classifications, patients with postoperative TAD values ≤ 30 mm and ≥ 20 mm and lag screws positioned center-center zone according to Cleveland were included in the study. Reduction quality was evaluated according to BRQC and CRQC using anteroposterior and lateral radiographs. Inter-system agreement was assessed using the McNemar-Bowker test and Cohen's kappa. Cutout predictive performances were compared using ROC analysis and the DeLong test. Inter- and intra-observer reliability was evaluated using weighted Cohen's kappa coefficients. A p-value < 0.05 was considered statistically significant.
resultsThe mean age of the patients was 79 ± 7.5 years, and 69.4% were female. 93 patients (86.1%) had bone union (non-cutout group), and 15 patients (13.9%) had cutout (cutout group). The mean bone union time was 12.54 ± 2.65 weeks. The mean time to cutout was 8.29 ± 5.52 weeks. No demographic differences were observed between groups. Both BRQC and CRQC significantly predicted cutout. However, cross-distribution and agreement analyses showed that reduction types associated with cutout were categorized into different risk groups, with CRQC demonstrating greater selectivity. ROC analysis showed AUC values of 0.79 (95% CI: 0.69-0.90) for CRQC and 0.68 (95% CI: 0.56-0.80) for BRQC, with a significant difference (ΔAUC = 0.10, p < .05). The reliability results demonstrated that CRQC exhibited consistently higher inter- and intra-observer agreement compared to BRQC.
conclusionCRQC more accurately and selectively identifies reduction types associated with cutout risk compared to BRQC. The use of CRQC can contribute to more effective intraoperative decision-making and postoperative risk stratification, especially in geriatric unstable intertrochanteric femur fractures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.